AmpliPhi Biosciences competitorsClear all

AmpliPhi Biosciences's top competitors include WuXi AppTec, Y-mAbs Therapeutics and Molecular Partners.
Discover new suppliers and conduct deeper comparison analysis with Craft for EnterpriseLearn more
Banner background
AmpliPhi Biosciences
AmpliPhi Biosciences
AmpliPhi Biosciences is a biotechnology company focused on developing novel bacteriophage-based therapeutics.
WuXi AppTec
WuXi AppTec
WuXi AppTec (药明康德, formerly known as WuXi PharmaTech) is a company providing research, development, and manufacturing services to discover and manufacture small molecule drugs and cell and gene therapies.
Y-mAbs Therapeutics
Y-mAbs Therapeutics
Y-mAbs Therapeutics is a clinical-stage biopharmaceutical company developing novel antibody therapeutics for oncology targets.
Molecular Partners
Molecular Partners
Molecular Partners is a company that develops biopharmaceutical products for serious diseases.
Founding Date
Founding Date
1989
Founding Date
2000
Founding Date
2014
Founding Date
2004
Type
Type
Private
Type
Public
Type
Public
Type
Public
Tags
Locations
Locations
San Diego, US HQ
Brookvale, AU
Ljubljana, SI
Richmond, US
Locations
Shanghai, CN HQ
Beijing, CN
Changzhou Shi, CN
Chengdu, CN
Nantong, CN
Shanghai, CN
Shanghai, CN
see more
Locations
New York, US HQ
Hørsholm, DK
Nutley, US
Nutley, US
Locations
Zürich-Schlieren, CH HQ
Cambridge, US
Employees
Employees
303% decrease
Employees
27,2724% increase
Employees
3239% increase
Employees
145
Valuation ($)
Valuation ($)
N/A
Valuation ($)
57.5 b
Valuation ($)
1.4 b
Valuation ($)
N/A
Twitter followers
Twitter followers
519
Twitter followers
4.7 k
Twitter followers
N/A
Twitter followers
258
Number of tweets (last 30 days)
Number of tweets (last 30 days)
N/A
Number of tweets (last 30 days)
23
Number of tweets (last 30 days)
N/A
Number of tweets (last 30 days)
13
Average likes per tweet (last 30 days)
Average likes per tweet (last 30 days)
N/A
Average likes per tweet (last 30 days)
0.8
Average likes per tweet (last 30 days)
N/A
Average likes per tweet (last 30 days)
3
Percentage of tweets with engagement (last 30 days)
Percentage of tweets with engagement (last 30 days)
N/A
Percentage of tweets with engagement (last 30 days)
60.87%
Percentage of tweets with engagement (last 30 days)
N/A
Percentage of tweets with engagement (last 30 days)
84.62%
Alexa Website Rank
Alexa Website Rank
N/A
Alexa Website Rank
192960
Alexa Website Rank
418444
Alexa Website Rank
173123
Employee Rating
Employee Rating
5
Employee Rating
3.1
Employee Rating
N/A
Employee Rating
N/A

Financial

Revenue (est.)
Revenue (est.)
N/A
Revenue (est.)
¥16.5b (FY, 2020)
Revenue (est.)
$20.8m (FY, 2020)
Revenue (est.)
N/A
Net income
Net income
($19.5m) (FY, 2019)
Net income
¥3b (FY, 2020)
Net income
($119.3m) (FY, 2020)
Net income
N/A

Funding

Total funding raised
Total funding raised
$ 44m
Total funding raised
$ 902.6m
Total funding raised
$ 80m
Total funding raised
N/A
For sources of this data, please see the company profile

View company profiles

WuXi AppTec
HQ
Shanghai, CN
Employees
27,272↑ 4% increase

WuXi AppTec (药明康德, formerly known as WuXi PharmaTech) is a company providing research, development, and manufacturing services to discover and manufacture small molecule drugs and cell and gene therapies.

View company
Y-mAbs Therapeutics
HQ
New York, US
Employees
32↑ 39% increase

Y-mAbs Therapeutics is a clinical-stage biopharmaceutical company developing novel antibody therapeutics for oncology targets.

View company
Molecular Partners
HQ
Zürich-Schlieren, CH
Employees
145

Molecular Partners is a company that develops biopharmaceutical products for serious diseases.

View company